PARP 저해제 바이오마커 시장 : 제품별, 서비스별, 용도별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

PARP Inhibitor Biomarkers Market size was valued at USD 915.8 Million in 2023, expanding at a CAGR of 8.80% from 2024 to 2032.

An agent that inhibits the cellular PARP enzyme. When DNA is broken, PARP aids in its repair. Numerous factors, including radiation, UV light exposure, some anticancer medications, and other compounds found in the environment, can harm DNA. In cancer treatment, PARP blocking may assist in preventing cancer cells from repairing their damaged DNA, which would ultimately lead to their demise. Known also as poly (ADP-ribose) polymerase inhibitors, PARP inhibitors are a class of targeted medicine.

PARP Inhibitor Biomarkers Market- Market Dynamics

Rising Costs for Cancer Management and Treatment to Propel Market Growth

Growing costs for the management and treatment of are anticipated to support market expansion. For instance, a journal paper from October 2022 in the Lancet Regional Health reported on treatment attrition and catastrophic costs for patients seeking full colorectal cancer therapy in India. Of the 226 patients that were included, four were lost to follow-up and 20 passed away within six months of receiving a treatment plan. Treatment for colorectal cancer cost, on average, 407,508 Indian Rupees (INR/5340 USD). The patient's PARP (median 330,277 INR/4328 USD) was the largest contributor to this total cost.

PARP Inhibitor Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.80 % over the forecast period (2024-2032)

Based on service segmentation, the BRCA 1 & 2 testing category was predicted to show maximum market share in the year 2023

Based on application segmentation, the breast cancer category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

PARP Inhibitor Biomarkers Market- Segmentation Analysis:

The Global PARP Inhibitor Biomarkers Market is segmented on the basis of Product, Service, Application, and Region.

The market is divided into two categories based on product: Kits and Assays. The kits category dominates the market because these kits are used to test for and diagnose diseases associated with mutations and changes in genes. One of the most prevalent diseases linked to inherited DNA mutations is breast cancer. In order to address the growing demand for accurate and efficient diagnostics, major players in the market are continuously concentrating on developing new solutions. One FDA-approved test for determining individuals with advanced ovarian cancer who have a positive homologous recombination deficiency (HRD) status is myChoice CDx from Myriad Genetics, Inc.

The market is divided into the following categories based on application: Breast Cancer, Ovarian Cancer, and Others. The oncology category dominates the market and is likely to maintain its dominance during the forecast period. The increasing frequency of breast cancer linked to gene alterations brought on by BRCA1 or BRCA2 genetic mutations is thought to be the reason for the segment's expansion. The WHO article from February 2023 states that It is predicted that 2.5 million people would be affected by breast cancer by 2040. Breast cancer is the most common type of cancer in women and the main cause of cancer-related deaths in women in 95% of the world's countries. In spite of this, survival rates differ greatly, and the bulk of deaths take place in low- and middle-income nations. Over the past three decades, breast cancer mortality rates have significantly decreased in high-income countries, whereas low- and middle-income countries have not seen a comparable decline.

PARP Inhibitor Biomarkers Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for PARP inhibitor biomarkers. This high percentage can be attributed to rising cancer treatment costs, advances in genomic technologies, and rising cancer prevalence. An article from the American Cancer Society projects that in 2022, there will be about 609,360 cancer-related deaths and over 1.9 million new cancer cases diagnosed in the United States. As a result, as cancer is becoming more common, more patients are using genetic testing to identify potential candidates for PARP inhibitor therapy, which is driving up the cost of biomarker testing.

In addition, the PARP inhibitor biomarkers market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific ascribed to the existence of significant regional and national market participants including Thermo Fisher Scientific, Inc., QIAGEN, and Illumina, Inc. The region's growth is also expected to be fueled by government initiatives to improve healthcare infrastructure, a rise in per capita income that leads to a greater adoption of diagnostic and therapy products, and significantly increased investments in PARP inhibitor biomarkers technologies throughout the region. Over the course of the forecast period, emerging nations like China, Japan, and India are expected to fuel the market expansion due to the growing usage of smartphones with new advanced features.

PARP Inhibitor Biomarkers Market- Competitive Landscape:

Among the leading businesses in the field are Ambry Genetics, Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., and Illumina, Inc. A highly concentrated market is indicated by the fact that a small group of producers have the majority of the market share. To counter the intense competition, these companies have turned to a variety of strategies, including partnerships, mergers and acquisitions, and the creation of new products.

Recent Developments:

February 2024: The genetic testing and precision medicine startup Myriad Genetics, Inc. has successfully acquired a number of assets from Intermountain Health's Intermountain Precision Genomics (IPG) laboratory group. The purchase includes his CLIA-certified laboratory in St. George, Utah, as well as Precision Fluid Testing and Precision Oncology Testing.

January 2024: ASCO and SSO guidelines about germline testing for breast cancer patients are something that Myriad Genetics, Inc., a manufacturer of genetic testing and precision medicine, has stated its support for. The business highlights the updating of the ASCO-SSO guidelines as a major step forward in the integration of genetics into patient treatment.

January 2023: Finding novel indicators for prostate cancer resistance to PARP medicines is made possible in large part by CRISPR technology. Researchers have used genome-wide CRISPR knockout screens to investigate the ways in which distinct genetic alterations affect PARP drug effectiveness. The identification of MMS22L, a gene that, when deleted, dramatically improves the sensitivity to PARP inhibitors, is a noteworthy finding from these investigations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PARP INHIBITOR BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Myriad Genetics, Inc.

CENTOGENE N.V.

Thermo Fisher Scientific, Inc.

Illumina, Inc.

Agilent Technologies, Inc.

Amoy Diagnostics Co., Ltd.

Invitae Corporation

Ambry Genetics

NeoGenomics Laboratories.

QIAGEN

Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

• Kits
• Assays

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

• BRCA 1 & 2 Testing
• HRD Testing
• HRR Testing
• Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Breast Cancer
• Ovarian Cancer
• Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. PARP Inhibitor Biomarkers Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. PARP Inhibitor Biomarkers Market Snippet by Product
  • 2.1.2. PARP Inhibitor Biomarkers Market Snippet by Services
  • 2.1.3. PARP Inhibitor Biomarkers Market Snippet by Application
  • 2.1.4. PARP Inhibitor Biomarkers Market Snippet by Country
  • 2.1.5. PARP Inhibitor Biomarkers Market Snippet by Region
• 2.2. Competitive Insights

3. PARP Inhibitor Biomarkers Key Market Trends

• 3.1. PARP Inhibitor Biomarkers Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. PARP Inhibitor Biomarkers Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. PARP Inhibitor Biomarkers Market Opportunities
• 3.4. PARP Inhibitor Biomarkers Market Future Trends

4. PARP Inhibitor Biomarkers Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. PARP Inhibitor Biomarkers Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. PARP Inhibitor Biomarkers Market Landscape

• 6.1. PARP Inhibitor Biomarkers Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. PARP Inhibitor Biomarkers Market - By Product

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
  • 7.1.2. Kits
  • 7.1.3. Assays

8. PARP Inhibitor Biomarkers Market - By Services

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Services, 2023 & 2032 (%)
  • 8.1.2. BRCA 1 & 2 Testing
  • 8.1.3. HRD Testing
  • 8.1.4. HRR Testing
  • 8.1.5. Others

9. PARP Inhibitor Biomarkers Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 9.1.2. Breast Cancer
  • 9.1.3. Ovarian Cancer
  • 9.1.4. Others

10. PARP Inhibitor Biomarkers Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. PARP Inhibitor Biomarkers Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. PARP Inhibitor Biomarkers Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. PARP Inhibitor Biomarkers Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. PARP Inhibitor Biomarkers Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. PARP Inhibitor Biomarkers Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- PARP Inhibitor Biomarkers Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Myriad Genetics, Inc.
  • 11.2.2. CENTOGENE N.V.
  • 11.2.3. Thermo Fisher Scientific, Inc.
  • 11.2.4. Illumina, Inc.
  • 11.2.5. Agilent Technologies, Inc.
  • 11.2.6. Amoy Diagnostics Co., Ltd.
  • 11.2.7. Invitae Corporation
  • 11.2.8. Ambry Genetics
  • 11.2.9. NeoGenomics Laboratories.
  • 11.2.10. QIAGEN.
  • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us